US Airways Is on a ...
Health Care: Drugs
Biomarin Pharmaceutical Inc. (BMRN: NASDAQ)
$65.00 2.57 | 4.12%
05/21/13 - 04:00 PM ET
1.81M / 1.28M
Vol / Avg. Vol:63.37 / 62.43
Open / Prev. Close:62.71 - 65.11
Today's Range:34.30 - 71.56
52 Wk Range:26.89%
Performance YTD:TheStreet Rating:
Portfolios with BMRN
- Portfolio NameUser Type
- User4 Overvalued Biotechs
- ProColumbia Wanger Asset Manag...
- ProJohn Griffin - Blue Ridge C...
- ProDaniel Loeb - Third Point
- UserMike Fatah's Mega Stock Por...
- ContributorCash Burners September 2012
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor22 Biopharma Stocks With Br...
Latest BMRN Headlines from TheStreet
- Biomarin Reaches New 52-Week High (BMRN) 04.19.13 | 03:04 pm
- BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 04.18.13 | 09:04 am
- Short Interest Moves 62% Lower For BMRN 04.10.13 | 02:04 pm
- Biomarin Stock Hits New 52-Week High (BMRN) 04.10.13 | 01:04 pm
- BioMarin To Host First Quarter 2013 Financial Results Conference Call And Webcast On Thursday, April 25 At 5:00 P.m. ET 04.04.13 | 09:04 am
- Mad Money Uncovered: Biomarin and Alexion Orphan Drug Stalwarts
04.02.13 | 11:04 am - Cramer's Top Stock Picks: HES ALXN BMRN NFLX ENB AWK 04.02.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Checking My List 04.01.13 | 07:04 pm
- Biomarin Stock Hits New 52-Week High (BMRN) 04.01.13 | 10:04 am
- BioMarin Submits CTA For BMN-190 For Batten Disease 04.01.13 | 09:04 am
Press Releases for BMRN
- IU Confidential Publishes Biotech Investment Report - PR Newswire 07.28.11 | 09:07 am
- BioMarin Launches Firdapse In The European Union - PR Newswire 04.19.10 | 09:04 am
- BioMarin To Present At The Barclays Capital Global Healthcare Conference - PR Newswire 03.17.10 | 09:03 am
- BioMarin To Acquire LEAD Therapeutics - PR Newswire 02.04.10 | 04:02 pm
Partner Headlines for BMRN
- Aetna Offloads Business and 4 Stocks At 52-Week Highs - Wall St. Cheat Sheet 04.02.13 | 09:04 am
- UPDATE: Piper Jaffray Raises PT on BioMarin Pharmaceutical on Positive Trial Results - Benzinga 03.20.13 | 09:03 am
- Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy - NASDAQ 03.14.13 | 04:03 pm
- After-Hours Earnings Report for February 21, 2013 : AIG, HPQ, PSA, NEM, INTU, SWN, COG, JWN, SBAC, MHK, BMRN, TS - NASDAQ 02.21.13 | 07:02 pm
- Four Biotech Stocks On The Clock - Seeking Alpha 02.19.13 | 09:02 am
- BioMarin's Expanding Product Portfolio Will Lead To Gains In 2013 - Seeking Alpha 12.31.12 | 09:12 am
- Pre-Market Most Active for Nov 5, 2012 : BAC, QQQ, AAPL, BMRN, GFA, BHP, FB, UBS, RIG, NOK, ZNGA, INTC - NASDAQ 11.05.12 | 01:11 pm
- Pipeline Progress at BioMarin - Analyst Blog - Zacks 09.28.12 | 06:09 pm
- Biotechs In Motion As New Drug Pipeline Brims - Investor's Business Daily 07.27.12 | 04:07 pm
- Harley Davidson OPTIMISM and 4 Analyst Notes Making Rounds Now - Wall St. Cheat Sheet 07.02.12 | 03:07 am
